Literature DB >> 31796572

Trends in HbA1c and LDL Cholesterol in Patients With Type 2 Diabetes Receiving First-Time Treatment in Northern Denmark, 2000-2017: Population-Based Sequential Cross-Sectional Analysis.

Jakob S Knudsen1, Adam Hulman2,3,4, Pernille F Rønn3,5, Torsten Lauritzen2, Henrik T Sørensen6, Daniel R Witte2,3, Reimar W Thomsen6.   

Abstract

Entities:  

Year:  2019        PMID： 31796572     DOI： 10.2337/dc19-0527

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020.

Authors:  Martina Ambrož; Sieta T de Vries; Klaas Hoogenberg; Petra Denig
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

2.  Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study.

Authors:  Jakob S Knudsen; Signe S Knudsen; Adam Hulman; Daniel R Witte; Edward W Gregg; Torsten Lauritzen; Lars Pedersen; Henrik T Sørensen; Reimar W Thomsen
Journal:  Lancet Reg Health Eur       Date:  2022-01-01

3.  Trends in HbA1c thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients.

Authors:  Martina Ambrož; Sieta T de Vries; Klaas Hoogenberg; Petra Denig
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-09-21       Impact factor: 2.890

4.  Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997-2017: Time trends in incidence and HbA1c and glucose-lowering drug use before and after hypoglycaemia.

Authors:  Mads Bisgaard Bengtsen; Jakob Schöllhammer Knudsen; Maria Bisgaard Bengtsen; Niels Møller; Reimar Wernich Thomsen
Journal:  Endocrinol Diabetes Metab       Date:  2021-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.